Ticker Details
DexCom, Inc. DexCom Inc designs, develops and commercializes continuous glucose monitoring systems for ambulatory use by people with diabetes and for use by healthcare providers in the hospital for the treatment of both diabetic and non-diabetic patients.
IPO Date:	April 14, 2005
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$24.64B
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$1.71 | 2.03%
Avg Daily Range (30 D):	$0.90 | 1.34%
Avg Daily Range (90 D):	$0.86 | 1.27%

Institutional Daily Volume
Avg Daily Volume:	1.35M
Avg Daily Volume (30 D):	2.74M
Avg Daily Volume (90 D):	3.61M

Trade Size
Avg Trade Size (Sh.):	89
Avg Trade Size (Sh.) (30 D):	54
Avg Trade Size (Sh.) (90 D):	61

Institutional Trades
Total Institutional Trades:	20,539
Avg Institutional Trade:	$7.23M
Avg Institutional Trade (30 D):	$8.78M
Avg Institutional Trade (90 D):	$8.17M
Avg Institutional Trade Volume:	.13M
Avg Institutional Trades (Per Day):	5

Market Closing Trades
Avg Closing Trade:	$24.66M
Avg Closing Trade (30 D):	$58.65M
Avg Closing Trade (90 D):	$57.47M
Avg Closing Volume:	362.08K

News

Mar 15, 2026 @ 11:05 PM This Biotech Stock Up Nearly 100% in a Year Has Dr... Source: Jonathan Ponciano

Mar 15, 2026 @ 2:30 PM Sotera Health Shares Rise 18% in a Year. Here's Wh... Source: Jonathan Ponciano

Mar 10, 2026 @ 7:27 PM 2 Growth Stocks to Hold for the Next Decade Source: Prosper Junior Bakiny

Feb 25, 2026 @ 2:15 PM Got $10,000? I Think DexCom Stock Could Be a Quiet... Source: Prosper Junior Bakiny

Feb 13, 2026 @ 6:48 PM Small Caps, Silver Rally As Inflation Cools Furthe... Source: Piero Cingari

Financials
	TTM	Q4 2025	FY 2025
Basic EPS	$2.14	$.69	$2.14
Diluted EPS	$2.09	$.67	$2.09
Revenue	$4.66B	$1.26B	$4.66B
Gross Profit	$2.8B	$792.7M	$2.8B
Net Income / Loss	$836.3M	$267.3M	$836.3M
Operating Income / Loss	$911.8M	$323M	$911.8M
Cost of Revenue	$1.86B	$466.9M	$1.86B
Net Cash Flow	$311.8M	$-917.8M	$311.8M
PE Ratio	30.21

Splits
Jun 13, 2022	4:1